IUC26697-95

Abstract Code: IUC26697-95 First Line Tyrosine Kinase Inhibitors (TKIs) in metastatic Renal Cell Cancer (mRCC)- A regional cancer Centre experience. R. Gul 1, O. Oghenevwede 2, E. Fetherston 1, O. Shahin 1, K. Kumar 2 (1) Freeman Hospital, Newcastle upon Tyne –...

IUC26695-93

Abstract Code: IUC26695-93   Real-world Outcomes of First-line Immune Checkpoint Inhibitor–Tyrosine Kinase Inhibitor Combination Therapy in Metastatic Renal Cell Carcinoma: A Regional Cancer Centre Experience R. Gul 1, E. Fetherston 1, O. Oghenevwede 2, O. Shahin...

IUC26694-92

Abstract Code: IUC26694-92   Stereotactic Body Radiotherapy and Immunotherapy for Metastatic Renal Cell Carcinoma Croatian Uro-Oncology Network Experience H. Brcic 1, J. Murgic 1, K. Brcic 2, M. Lekic 3, I. Tomaskovic 4, M. Jazvic 1, D. Schwarz 3, M. Penc 5, T....

IUC26693-91

Abstract Code: IUC26693-91   CHOLESTEROL HOMEOSTASIS AND IMMUNE-INFLAMMATORY PROFILES IN PATIENTS WITH mRCC RECEIVING IMMUNOTHERAPY P. Tuttobene 1, M. Maffezzoli 2, G. Leali 1, M. Pluchino 3, E. Favari 4, G. Mazzaschi 3, F. Pecci 3, M. Tiseo 3, M. Di Maio 5, S....

IUC26691-89

Abstract Code: IUC26691-89   Real-World Outcomes of Delayed Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Following Systemic Therapy: A Tertiary Centre Experience M. Hassan 1 , H. Warren 1 , R. Nair 1 , D. Crawley 1 , A. Khan 1 , A. Fernando 1 , T....

IUC26690-88

Abstract Code: IUC26690-88   Cannabinoid Receptor Profiling Reveals a Low CB1 and High CB2 signature in Clear Cell Renal Cell Carcinoma S. Singh 1, S. Pattanaik 2, R.S. Mavuduru 2, N. Kakkar 2, G.S. Bora 2 (1) PhD, Post-Graduate Institute of Medical Education and...
error: Content is protected !!